ロード中...
Long-term postmenopausal hormone therapy and endometrial cancer
Estrogen alone therapy (ET) or estrogen and progestin (EPT) as menopausal hormone therapy (HT) has been commonly used to alleviate menopausal symptoms. Treatments containing ≥10 days/month (d/m) of progestin are considered relatively safe with respect to endometrial cancer risk. However, the endomet...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2821215/ https://ncbi.nlm.nih.gov/pubmed/20086105 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-09-0712 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|